Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 156-168
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.156
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.156
Table 4 Recomendations for renal function evaluation in subgroups of patients with cirrhosis
Differentiate prerenal kidney disease, hepatorenal syndrome and acute tubular necrosis | Angeli et al[5] algorithm |
Acute kidney injury | Modified cirrhosis–acute kidney injury classification sCr increase ≥ 0.3 mg/dL (≥ 26.4 μmol/L) or more than 150% (1.5 fold from baseline) within 48 h from the first measurement[12] |
Chronic kidney disease | KDOQI[49] guidelines Glomerular filtration rate below 60 mL/min for more than three months, calculated using the modified diet in renal disease-6 formula chronic kidney disease epidemiology collaboration Cys C-Cr equation[51] |
Critically ill cirrhotic patients | RIFLE score[18,19] MBRS score[61,62] combining mean arterial pressure, bilirubin, respiratory failure and sepsis |
Candidates for liver transplantation | Exogenous filtration markers If there is suspicion for parenchymal disease and Glomerular filtration rate is between 30-60 mL/min consider renal biopsy |
Advanced cirrhosis | Cystatin C |
Difficulties in differentiation of acute tubular necrosis | NGAL |
All patients with cirrhosis in every stage of liver disease | Renal resistive index estimation by renal duplex doppler ultrasound |
- Citation: Pipili C, Cholongitas E. Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther 2014; 5(3): 156-168
- URL: https://www.wjgnet.com/2150-5349/full/v5/i3/156.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v5.i3.156